Login / Signup

Protective effect of pre-existing natural immunity in a nonhuman primate reinfection model of congenital cytomegalovirus infection.

Matilda J MoströmShan YuDollnovan TranFrances SaccoccioCyril J VersozaDaniel MalouliAnne MirzaSarah ValenciaMargaret GilbertRobert BlairScott HansenPeter BarryKlaus FrühJeffrey D JensenSusanne P PfeiferTimothy F KowalikSallie R PermarAmitinder Kaur
Published in: bioRxiv : the preprint server for biology (2023)
Globally, pregnancies in CMV-seropositive women account for the majority of cases of congenital CMV infection but the immune responses needed for protection against placental transmission in mothers with non-primary infection remains unknown. Recently, we developed a nonhuman primate model of primary rhesus CMV (RhCMV) infection in which placental transmission and fetal loss occurred in RhCMV-seronegative CD4+ T lymphocyte-depleted macaques. By conducting similar studies in RhCMV-seropositive dams, we demonstrated the protective effect of pre-existing natural CMV-specific CD8+ T lymphocytes and humoral immunity against congenital CMV after reinfection. A 5-fold reduction in congenital transmission and complete protection against fetal loss was observed in dams with pre-existing immunity compared to primary CMV in this model. Our study is the first formal demonstration in a relevant model of human congenital CMV that natural pre-existing CMV-specific maternal immunity can limit congenital CMV transmission and its sequelae. The nonhuman primate model of non-primary congenital CMV will be especially relevant to studying immune requirements of a maternal vaccine for women in high CMV seroprevalence areas at risk of repeated CMV reinfections during pregnancy.
Keyphrases
  • immune response
  • pregnancy outcomes
  • type diabetes
  • metabolic syndrome
  • polycystic ovary syndrome
  • birth weight
  • body mass index
  • preterm birth
  • case control